Recognition & Certification


  • Apostle awards image 04/2019: ISO13485:2016 & ISO9001:2015 (Menlo Park, CA, USA site, see certificates below)
  • Apostle awards image 03/2019: ISO13485:2016 (Shenzhen, China site, see certificates below)
  • Apostle awards image 02/2019: Beckman Coulter Life Sciences Enters Liquid Biopsy Partnership with Apostle
  • Apostle awards image 02/2019: Independent validation study presented at AGBT 2019
  • Apostle awards image 11/2018: Apostle and Apostle MiniMax trademarks registration
  • Apostle awards image 09/2018: ISO9001:2015 (Shenzhen, China site, see certificates below)
  • Apostle awards image 04/2018: Stanford University StartX
  • Apostle awards image 01/2018: BioSpace Top 20 Life Science Startups
  • Apostle awards image 07/2017: PCT patent application submission
  • Apostle awards image 09/2017: Finalist of North America Region, CACSC
  • Apostle awards image 08/2017: Amazon Web Service Activate Gold Premium Support
  • Apostle awards image 07/2017: Apostle's 1st PCT patent application submission
  • Apostle awards image 07/2017: Forbes China 30 Under 30
  • Apostle awards image 2002- Certification and License: ABMGG, States of California & New York, ACMG, Harvard Medical School
awards image04/2019: ISO13485:2016 & ISO9001:2015 (Menlo Park, CA, USA site)

Apostle ISO13485 image Apostle ISO9001 image

Apostle Inc is pleased to receive the Certificates of Conformance to certify that Quality Management System of Apostle Inc. 1455 Adams Dr. Menlo Park, CA 94025, USA has been assessed by ABS Quality Evaluations, Inc. and found to be in conformance with the requirements set forth by: ISO13485:2016, and ISO9001:2015. The Quality Management System is applicable to DEVELOPMENT, MANUFACTURING, LICENSING AND SALES OF CONSUMABLES AND CHEMICALS FOR NUCLEIC ACID RESEARCH.

To download the certificates:
ISO13485:2016 Certificate of Conformance
ISO9001:2015 Certificate of Conformance

awards image03/2019: ISO13485:2016 (Shenzhen, China site)

Apostle ISO13485 image

Apostle Inc is pleased to have been awarded ISO 13485 certification for our Nucleic Acid Extraction or Purification Reagents of Research and Development, Production, and Sales in our manufacturing facility located in Shenzhen, China. This certificate demonstrates our commitment to providing a high-quality and consistent service to our clients and our ongoing investment in technology, development, processes and procedures.

ISO 13485, Medical devices – Quality management systems – Requirements for regulatory purposes, is an internationally agreed standard that sets out the requirements for a quality management system specific to the medical devices industry. It has recently been revised, with the new version published in March 2016.

Apostle awards image 02/2019: Beckman Coulter Life Sciences Enters Liquid Biopsy Partnership with Apostle

Beckman Coulter

Beckman Coulter Life Sciences announces an exclusive partnership with Apostle, a liquid biopsy company, on Feb 28, 2019.

For more information about this partnership:
https://www.beckman.com/news/liquid-biopsy-partnership-with-apostle

Apostle awards image 02/2019: Independent validation study presented at AGBT 2019

Beckman Coulter

Apostle MiniMaxTM technology is independently validated and the findings are presented at the Advances in Genome Biology and Technology (AGBT) 2019 meeting in Marco Island, FL. Apostle MiniMaxTM is efficient, clean, scalable, automatable, versatile, and novel.

Reference
* A new Scalable and automatable method for the extration of cfDNA. Saunders LP, Hur A, Niccum B, and Patel A. Advances in Genome Biology and Technology (AGBT). Feb 28, 2019 Marco Island, FL. (Conference abstract, #419). Download.

Apostle awards image 11/2018: Apostle and Apostle MiniMax trademarks registration

Apostle Inc is pleased to receive the trademark registration certificates for APOSTLE and APOSTLE MINIMAX from the United States Patent and Trademark Office on Nov 21, 2018. The registration dates for both trademarks are July 24, 2018.

awards image09/2018: ISO9001:2015 (Shenzhen, China site)

Apostle ISO9001 image

Apostle Inc is pleased to have been awarded ISO 9001 certification for our R&D, Manufacturing and Sales of Nucleic Acid Extraction and Purification Kits in our manufacturing facility located in Shenzhen, China. This certificate demonstrates our commitment to providing a high-quality and consistent service to our clients and our ongoing investment in technology, development, processes and procedures.

ISO 9001 is the international standard that specifies requirements for a quality management system (QMS). Organizations use the standard to demonstrate the ability to consistently provide products and services that meet customer and regulatory requirements. It is the most popular standard in the ISO 9000 series and the only standard in the series to which organizations can certify.

Apostle awards image04/2018: Stanford University StartX

Apostle StartX image

Apostle StartX image

StartX is a renowned educational non-profit that accelerates the development of Stanford's top entrepreneurs through experiential education and collective intelligence. The Stanford-StartX Fund (SSF), co-founded by StartX, Stanford University, and Stanford Health Care is available only to StartX companies with a Stanford-affiliated founder.

StartX alumni and trusted expert judges review and determine which teams are accepted. The acceptance rate has been between 8%-10%. Apostle is selected into the StartX Accelerator Program (Summer 2018 session), following one initial review, four interviews and due diligence.

Apostle awards image01/2018: BioSpace Top 20 Life Science Startups

Apostle Top 20 image

Apostle Top 20 image

Apostle Inc is selected into the Top 20 Life Science Startups to Watch in 2018 by BioSpace on January 2, 2018. The NextGen Bio Class of 2018 is "a list of 20 up-and-coming life science companies in North America that started up no earlier than 2015, a stellar group of companies that are already making an enormous impact on the industry now and will into the future."

Companies in the field of genomic sciences selected in the past three years include:

  • Freenome (Class of 2018): raised $77 million;
  • Grail (Class of 2017): raised $1.3 billion;
  • CRISPR (2016): IPO
  • Editas (2015): IPO
  • NextCode (2015): Acquired
Apostle awards image 11/2017: PCT patent application submission

Apostle PT image

Apostle Inc is pleased to submit its PCT patent application to the U.S. patent and trademark office on Nov 3, 2017.

Apostle awards image 09/2017: Finalist of North America Region, CACSC

Apostle CACSC image

Apostle won the Second Place in the Final of North America Region, CACSC,(Create@AlibabaCloud Startup Contest). Over 300 startups from North America have competed in CACSC, and 13 entered the final.

Apostle awards image08/2017: Amazon Web Service Activate Gold Premium Support

Apostle CACSC image

Apostle Inc is selected into the Amazon Web Service (AWS) Activate Program.The AWS Activate Program is designed for startups in select accelerators, incubators, Seed/VC Funds, and other startup-enabling organizations. Some of the world’s hottest startups, including Airbnb, Slack, and Robinhood, have leveraged the power of AWS to quickly scale.

Apostle awards image 07/2017: Apostle's 1st PCT patent application submission

Apostle PT image

Apostle Inc is pleased to submit its first PCT patent application to the U.S. patent and trademark office on July 25, 2017.

Apostle awards image07/2017: Forbes China 30 Under 30

Apostle Forbes 30u30 image

Forbes China named Apostle Inc’s co-Founder and VP of Chemistry, Bo Zhang, PhD, as one of the most brilliant young entrepreneurs in its annual “30 Under 30 China” list in the category of healthcare and science.

Apostle awards image 2002- Certification and License: ABMGG, States of California & New York, ACMG, Harvard Medical School

Apostle Inc’s co-Founder and SVP of Medicine, Wenqi Zeng, MD PhD is a board-certified clinical molecular geneticist and lab director holding certificates and licenses from American Board of Medical Genetics and Genomics (ABMGG), State of California, State of New York, and diploma from American College of Medical Genetics (ACMG), and Harvard Medical School Genetics Training Program.

Partnership


Beckman Coulter

Apostle partners with Beckman Coulter Life Sciences to provide access to our innovative nucleic acid isolation products to customers around the globe.

For more information about this partnership:
https://www.beckman.com/news/liquid-biopsy-partnership-with-apostle

To place an order, or for more product information, please visit Beckman Coulter's product webpage:
https://www.beckman.com/reagents/genomic/dna-isolation/from-plasma

Team


Apostle Inc
David Ge, President Apostle

David Ge, MD. PhD.CEO & President

  • 18+ years of research and industry experience in genomic sciences
  • U.S. Citizen through federal "Outstanding Professors and Researchers"
  • President of BioSciKin Co. & Simcere Diagnostics Co (2016-2017)
  • Director of Bioinformatics at Gilead Sciences, Inc (2011-2016)
  • Assistant Professor of Biostatistics & Bioinformatics, Duke University School of Medicine (2008-2011)
  • Ph.D. in Biostatistics & Genetic Epidemiology, CAMS & PUMC (2004)
  • Co-authored 70+ peer-reviewed papers, 5 in Nature and 1 in Science, over 16,000 citations.
Apostle Inc
Bo Zhang, VP of Chemistry

Bo Zhang, PhD.VP of Chemistry

Apostle Inc
Xin Guo, VP of Bioinformatics

Xin Guo, PhD.VP of Bioinformatics

  • 10+ years of research and industry experience in bioinformatics, artificial intelligence (AI), and HPC
  • VP of Bioinformatics, Simcere Diagnostics, Inc (2016-2017)
  • Group leader, research scientist of Bioinformatics at Gilead Sciences, Inc. Led the clinical phylogenomic project for Sovaldi®, a world-leading anti-HCV drug. (2012-2016)
  • Ph.D. in Computer Science, Duke University (2012)
  • M.S. in Informatics from Max Planck Institute, Germany (2006)
  • Led multiple publications in AI, including in PNAS.
Apostle Inc
Wenqi Zeng, SVP of Medicine

Wenqi Zeng, MD. PhD. FACMG.SVP of Medicine

  • 15+ years of research, clinics and industry experience in clinical diagnostics
  • Senior director of Molecular Genetics at Quest Diagnostics (2014-2017)
  • Director of Clinical Genomics at Ambry Genetics (2011-2014)
  • Qualified CAP CLIA lab director in CA, FL and MD; Qualified CAP inspection team leader
  • New York state COQ in molecular genetics and molecular oncology
  • PhD, Molecular Genetics
  • Fellow of clinical molecular genetics, human/medical genetics, Harvard Medical School
  • Holding diploma of ABMGG
Apostle Inc
Shuting Zhao, Scientist

Shuting Zhao, PhDScientist

  • 5+ years research experience in micro and nano scale biomaterials and their applications on regenerative medicine, cancer treatment, drug delivery and drug screening
  • PhD in Biomedical Engineering, Ohio State University
  • MS in Biomedical Engineering, Cornell University
  • First-author article in Nature Communications
  • 19 co-authored peer-reviewed publications in top journals and one US patent
  • HHMI Med into Grad Scholar in Ross Heart Hospital
Apostle Inc
Joshua Robinson, Principal Business Development Consultant

Joshua Robinson, PhDPrincipal Business Development Consultant

  • Innovation Leader, Colox, a Fortune 500 Consumer Packaged Goods company
  • Director, Nirmidas Biotech, Inc., a point-of-care diagnostic company
  • Senior Application Scientist, Beckman Coulter, an American company that develops, manufactures and markets products for complex biomedical testing in both diagnostics and life sciences laboratories .
  • Principal investigator, NIH R43 grant
  • PhD, Stanford University
  • BS, Purdue University

Advisory Board


SAB member Apostle
Charles Cantor, SAB member

Charles Cantor, PhD.

  • Member of National Academy of Sciences
  • Professor Emeritus, Biomedical Engineering, Boston University
  • Founder & Chief Scientific Officer at Sequenom, Inc. (NASDAQ: SQNM, acquired by LabCorp)
  • Chairman, Department of Biomedical Engineering, Boston University
  • Director, Center for Advanced Biotechnology, Boston University
  • Director, the Human Genome Project (HGP)
  • Ph.D., Biophysical Chemistry, University of California, Berkeley
  • A.B., Chemistry, Columbia University
full profile (wiki)
SAB member Apostle
John McHutchison, SAB member

John McHutchison, AO, MD.

  • Chief Scientific Officer, Head of Research and Development, Gilead Sciences (NASDAQ: GILD)
  • Officer of the Order of Australia in recognition of his distinguished service to medical research
  • Professor of Medicine, Duke University Medical Center, Associate Director at Duke Clinical Research Institute and Co-Director of the Duke Clinical and Translational Science Award.
  • Medicine and surgery degrees, University of Melbourne in Australia. Residency and fellowship, the Royal Melbourne Hospital. Member, the Royal Australasian College of Physicians.
full profile (Gilead)
SAB member Apostle
Dean Felsher, SAB member

Dean Felsher, MD. PhD.

  • Professor. Division of Oncology, Departments of Medicine and Pathology, Stanford University School of Medicine
  • Director, Translational Research and Applied Medicine; Director of Research, Division of Oncology; Associate Director, Director of Admissions, Medical Scientist Training Program (MSTP); Co-Director, Translational Cancer Nanotechnology Training Program; Stanford University School of Medicine
  • Elected Member, Association of American Physicians
  • M.D. Ph.D., Medicine/Molecular Biology, UCLA
  • B.S., Chemistry, University of Chicago
full profile (Stanford)
SAB member Apostle
David Goldstein SAB member

David B. Goldstein, PhD.

  • John E. Borne Professor of Medical and Surgical Research, Columbia University
  • Director, Institute for Genomic Medicine, Columbia University Medical Center
  • Fellow, AAAS (American Association for the Advancement of Science)
  • Recipient, Royal Society Wolfson Research Merit Award
  • PhD, Theoretical Population Genetics, Stanford University
  • BS, Biology, UCLA
full profile (Columbia)
SAB member Apostle
hongyu zhao, SAB member

Hongyu Zhao, PhD.

  • Chairman, Biostatistics Department, Yale University
  • Ira V. Hiscock Professor of Biostatistics and Professor of Statistics and Genetics, Yale University
  • Fellow, AAAS (American Association for the Advancement of Science)
  • Fellow, Institute of Mathematical Statistics
  • Fellow, American Statistical Association
  • Ph.D., Statistics, University of California at Berkeley
  • B.S., Probability and Statistics, Peking University
full profile (Yale)
SAB member Apostle
Alexander Hartemink, SAB member

Alexander J. Hartemink, PhD.

  • Professor, Departments of Computer Science and Biology, Duke University
  • Faculty Director, the Office of Undergraduate Scholars and Fellows; Former Director of Graduate Program in Computational Biology and Bioinformatics (CBB), Duke University
  • Ph.D., Electrical Engineering and Computer Science, MIT
  • M.S., Electrical Engineering and Computer Science, MIT; M.Phil., Economics, Oxford University
  • B.S., Mathematics, Physics, and Economics (triple major), Duke University
full profile (Duke)